Corbus Pharmaceuticals Holdings (CRBP) EBITDA Margin (QoQ) (2015 - 2021)
Corbus Pharmaceuticals Holdings (CRBP) EBITDA Margin (QoQ) (2015 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 122.70 Mn | -40.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -202,706.00 |
| Jun 30, 2021 | -985,063.00 |
| Mar 31, 2021 | -117,005.00 |
| Dec 31, 2020 | 155,138.00 |
| Sep 30, 2020 | 1.06 Mn |
| Jun 30, 2020 | -1.16 Mn |
| Mar 31, 2020 | -179,121.00 |
| Dec 31, 2019 | 106,424.00 |
| Sep 30, 2019 | -97,493.00 |
| Jun 30, 2019 | 141,240.00 |
| Mar 31, 2019 | -49,381.00 |
| Dec 31, 2018 | 45,296.00 |
| Sep 30, 2018 | 8,617.00 |
| Jun 30, 2018 | -20,350.00 |
| Sep 30, 2017 | 120,857.00 |
| Jun 30, 2017 | -150,613.00 |
| Sep 30, 2016 | 33,860.00 |
| Jun 30, 2016 | -32,890.00 |
| Mar 31, 2016 | -4,152.00 |
| Dec 31, 2015 | 63,642.00 |